Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Subscribe
Pharma
Oncology
Vaccines
Asia
Cell & Gene Therapy
Drug Delivery
Executives
Manufacturing
Facilities
Recalls
Warning Letters
Marketing
Special Reports
Fierce 50
Special Report
Awards Gala
Trending
Supply Chain
AI and Machine Learning
Awards
Outsourcing Awards
Innovation Awards
AI Innovation Awards
Pharma Marketing Awards
Resources
Podcasts
Fierce Events
Industry Events
Webinars
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
follicular lymphoma
Pharma
Roche reports positive confirmatory trial readout for Lunsumio
Roche's positive phase 3 readout sets up a potential three-way battle with AbbVie/Genmab and Incyte.
Angus Liu
Sep 17, 2026 11:25am
Safety signals prompt Ipsen to withdraw cancer med Tazverik
Mar 9, 2026 10:07am
Roche's bispecific Lunsumio goes subcutaneous
Dec 22, 2025 10:15am
FDA OKs BMS' Breyanzi as first CAR-T for marginal zone lymphoma
Dec 5, 2025 11:00am
Genmab touts new data that set up Epkinly for FL expansion
Aug 8, 2025 7:25am
ASH: Roche's subQ Lunsumio matches IV version in lymphoma
Dec 9, 2024 3:16pm
